Insulet Corp Files 10-Q for Q1 2024
Ticker: PODD · Form: 10-Q · Filed: 2024-05-10T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
Insulet's Q1 2024 10-Q is in, check financials.
AI Summary
Insulet Corporation reported its first quarter 2024 results for the period ending March 31, 2024. The company's filing details its financial position and operational performance, including various financial metrics and disclosures relevant to its business as a medical device manufacturer.
Why It Matters
This 10-Q filing provides investors and analysts with a detailed look into Insulet's financial health and operational status during the first quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal significant financial health indicators or operational challenges.
Key Numbers
- 2024 Q1 — Reporting Period (Covers the first quarter of 2024)
- 1231 — Fiscal Year End (Indicates the company's fiscal year concludes on December 31st)
Key Players & Entities
- INSULET CORP (company) — Filer of the 10-Q report
- 20240331 (date) — End of the reporting period
- 20240510 (date) — Filing date of the report
- 978-600-7000 (phone_number) — Insulet Corp business phone number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2024, ending on March 31, 2024.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 10, 2024.
What is the company's Standard Industrial Classification (SIC) code?
The company's SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
What is the state of incorporation for Insulet Corp?
Insulet Corp is incorporated in Delaware (DE).
What is the business address of Insulet Corp?
The business address of Insulet Corp is 100 Nagog Park, Acton, MA 01720.
From the Filing
0001145197-24-000022.txt : 20240510 0001145197-24-000022.hdr.sgml : 20240510 20240509175506 ACCESSION NUMBER: 0001145197-24-000022 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240510 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 24932200 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 10-Q 1 podd-20240331.htm 10-Q podd-20240331 false 2024 Q1 0001145197 December 31 http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations 0.0044105 http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure podd:notice podd:day iso4217:USD podd:option 0001145197 2024-01-01 2024-03-31 0001145197 2024-05-02 0001145197 2024-03-31 0001145197 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-03-31 0001145197 us-gaap:NonrelatedPartyMember 2023-12-31 0001145197 us-gaap:RelatedPartyMember 2024-03-31 0001145197 us-gaap:RelatedPartyMember 2023-12-31 0001145197 us-gaap:NonrelatedPartyMember 2024-01-01 2024-03-31 0001145197 us-gaap:NonrelatedPartyMember 2023-01-01 2023-03-31 0001145197 us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001145197 us-gaap:RelatedPartyMember 2023-01-01 2023-03-31 0001145197 2023-01-01 2023-03-31 0001145197 us-gaap:CommonStockMember 2023-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001145197 us-gaap:RetainedEarningsMember 2023-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001145197 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001145197 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001145197 us-gaap:CommonStockMember 2024-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001145197 us-gaap:RetainedEarningsMember 2024-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001145197 us-gaap:CommonStockMember 2022-12-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001145197 us-gaap:RetainedEarningsMember 2022-12-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001145197 2022-12-31 0001145197 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001145197 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001145197 us-gaap:CommonStockMember 2023-03-31 0001145197 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001145197 us-gaap:RetainedEarningsMember 2023-03-31 0001145197 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001145197 2023-03-31 0001145197 us-gaap:ShippingAndHandlingMember 2024-01-01 2024-03-31 0001145197 us-gaap:ShippingAndHandlingMember 2023-01-01 2023-03-31 0001145197 podd:U.S.OmnipodMember 2024-01-01 2024-03-31 0001145197 podd:U.S.OmnipodMember 2023-01-01 2023-03-31 0001145197 podd:InternationalOmnipodMember 2024-01-01 2024-03-31 0001145197 podd:InternationalOmnipodMember 2023-01-01 2023-03-31 0001145197 podd:ProductOmnipodMember 2024-01-01 2024-03-31 0001145197 podd:ProductOmnipodMember 2023-01-01 2023-03-31 0001145197 podd:DrugDeliveryMember 2024-01-01 2024-03-31 0001145197 podd:DrugDeliveryMember 2023-01-0